The Patent Finder

GBP IP, LLC

Also on record
Records under this name other than patents GBP IP, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to GBP IP, LLC

PatentTitleStatus Expires Confidence
US 6,790,641Lentiviral vector particles resistant to complement inactivation
Formerly held
Term ended
Term ended Apr 29, 2023 · From the USPTO record
Term endedTerm ended Apr 29, 2023From the USPTO record
US 6,863,884Pseudotyped retroviral vectors
Formerly held
Term ended
Term ended Apr 29, 2023 · From the USPTO record
Term endedTerm ended Apr 29, 2023From the USPTO record
US 8,652,837Method and means for producing high titer, safe, recombinant lentivirus vectors
Formerly held
Term ended
Term ended Feb 9, 2023 · From the USPTO record
Term endedTerm ended Feb 9, 2023From the USPTO record
US 7,179,903Liver specific transcriptional enhancer
Formerly held
Term ended
Term ended Jan 17, 2023 · From the USPTO record
Term endedTerm ended Jan 17, 2023From the USPTO record
US 6,808,905Lentiviral vectors encoding clotting factors for gene therapy
Formerly held
Term ended
Term ended Jul 16, 2022 · From the USPTO record
Term endedTerm ended Jul 16, 2022From the USPTO record
US 7,745,179Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same
Formerly held
Term ended
Ended no later than May 14, 2022 · From the USPTO record
Term endedEnded no later than May 14, 2022From the USPTO record
US 6,797,512Selection system for generating efficient packaging cells for lentiviral vectors
Formerly held
Term ended
Term ended Sep 12, 2021 · From the USPTO record
Term endedTerm ended Sep 12, 2021From the USPTO record
US 7,250,299Method and means for producing high titer, safe, recombinant lentivirus vectors
Formerly held
Term ended
Term ended Apr 26, 2020 · From the USPTO record
Term endedTerm ended Apr 26, 2020From the USPTO record
US 6,165,782Method and means for producing high titer, safe, recombinant lentivirus vectors
Formerly held
Term ended
Term ended Mar 18, 2019 · From the USPTO record
Term endedTerm ended Mar 18, 2019From the USPTO record
US 6,218,187Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
Formerly held
Term ended
Term ended Mar 11, 2019 · From the USPTO record
Term endedTerm ended Mar 11, 2019From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited